Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR Market Closed
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shedir Pharma Srl Unipersonale
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Other Long-Term Assets
€528k
CAGR 3-Years
-6%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Other Long-Term Assets
€104.2m
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
13%
P
Pierrel SpA
MIL:PRL
Other Long-Term Assets
€5.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Friulchem SpA
MIL:FCM
Other Long-Term Assets
€434.1k
CAGR 3-Years
9%
CAGR 5-Years
23%
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Other Long-Term Assets?
Other Long-Term Assets
528k EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Other Long-Term Assets amounts to 528k EUR.

What is Shedir Pharma Srl Unipersonale's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
15%

Over the last year, the Other Long-Term Assets growth was -33%. The average annual Other Long-Term Assets growth rates for Shedir Pharma Srl Unipersonale have been -6% over the past three years , 15% over the past five years .

Back to Top